NeuroSense Therapeutics

NeuroSense Therapeutics is a Biotech company tha focuses on the development of miRNAs as a novel treatment for ALS.

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
NeuroSense Therapeutics
12/03/2022
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
other
01/01/2016
"1-10"

NeuroSense Therapeutics is a Biotech company focusing on the development of an effective drug for ALS patients. Established in 2016, NeuroSense Therapeutics comprises ALS experts and professionals in the field of drug development for diseases of the CNS. The company's groundbreaking therapy is based on research done by pioneers in the ALS field. It is working on the development of a novel treatment for ALS, comprised of molecules which enhance the activity of multiple pertinent targets due to synergistic effect.